Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sessa

Showing results (31-40 of 570) with videos related to

Pageof 57
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2023
Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. TjalmaC Sessa, S Paluch-Shimon,
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2013
Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survivalMauro Siragusa, William C Sessa
British Journal of Pharmacology|October 21, 2018
Endothelial NOS: perspective and recent developmentsVictor Garcia, William C Sessa
Circulation Research|February 1, 1990
Dexamethasone selectively attenuates prostanoid-induced vasoconstrictor responses in vitroW C Sessa, A Nasjletti
American Journal of Human Genetics|March 3, 1999
Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental linksR D Rudic, W C Sessa
Cardiovascular Research|March 16, 2010
Spotlight on mechanisms of vascular inflammationFrancisco Sanchez-Madrid, William C Sessa
Circulation Research|July 3, 2020
Dynamic Protein Palmitoylation Cycling: A New Pathway Impacting Peripheral Arterial Disease?Nabil E Boutagy, William C Sessa
Cancer Cell|December 21, 2004
Antiangiogenic therapy: creating a unique "window" of opportunityMichelle I Lin, William C Sessa
Circulation Research|September 30, 2006
Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: more than a FLeeTing momentMichelle I Lin, William C Sessa
Bulletin Du Cancer|January 1, 1995
Platinum dose-intensity in solid tumors: pharmacological and clinical perspectivesO Pagani, C Sessa, F Cavalli
Pageof 57

Showing results (31-40 of 570) with videos related to

Sort By:
Pageof 57
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2023
Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. TjalmaC Sessa, S Paluch-Shimon,
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2013
Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survivalMauro Siragusa, William C Sessa
British Journal of Pharmacology|October 21, 2018
Endothelial NOS: perspective and recent developmentsVictor Garcia, William C Sessa
Circulation Research|February 1, 1990
Dexamethasone selectively attenuates prostanoid-induced vasoconstrictor responses in vitroW C Sessa, A Nasjletti
American Journal of Human Genetics|March 3, 1999
Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental linksR D Rudic, W C Sessa
Cardiovascular Research|March 16, 2010
Spotlight on mechanisms of vascular inflammationFrancisco Sanchez-Madrid, William C Sessa
Circulation Research|July 3, 2020
Dynamic Protein Palmitoylation Cycling: A New Pathway Impacting Peripheral Arterial Disease?Nabil E Boutagy, William C Sessa
Cancer Cell|December 21, 2004
Antiangiogenic therapy: creating a unique "window" of opportunityMichelle I Lin, William C Sessa
Circulation Research|September 30, 2006
Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: more than a FLeeTing momentMichelle I Lin, William C Sessa
Bulletin Du Cancer|January 1, 1995
Platinum dose-intensity in solid tumors: pharmacological and clinical perspectivesO Pagani, C Sessa, F Cavalli
Pageof 57